6.25p+0.00 (+0.00%)19 Jan 2022, 13:54
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Iq-Ai Limited Fundamentals

Company NameIq-Ai LimitedLast Updated2022-01-19
IndustryHealth Information ServicesSectorHealthcare
Shares in Issue182.508 mMarket Cap£11.41 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.4125Cash Equity Ratio0.2755
Quick Ratio1.1618Current Ratio1.16
Price To Book Value13.2100ROCE0

Iq-Ai Limited Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Iq-Ai Limited Company Financials

Assets20202019
Tangible Assets£1,283.00£2,710.00
Intangible Assets£889,177.00£567,396.00
Investments00
Total Fixed Assets£890,460.00£570,106.00
Stocks00
Debtors£36,916.00£17,221.00
Cash & Equivalents£478,910.00£865,875.00
Other Assets00
Total Assets£1.43 m£1.87 m
Liabilities20202019
Creditors within 1 year£361,589.00£208,866.00
Creditors after 1 year00
Other Liabilities0£8,948.00
Total Liabilities£361,589.00£208,866.00
Net assets£1.07 m£1.66 m
Equity20202019
Called up share capital£1.70 m£1.40 m
Share Premium£20.10 m£19.84 m
Profit / Loss-£717,534.00-£638,654.00
Other Equity£1.07 m£1.66 m
Preference & Minorities00
Total Capital Employed£1.07 m£1.66 m
Ratios20202019
Debt Ratio00
Debt-to-Equity00
Assets / Equity1.41251.4125
Cash / Equity0.27550.2755
EPS£-0.00-£0.01
Cash Flow20202019
Cash from operating activities-£423,222.00-£524,610.00
Cashflow before financing-£355,316.00£951,110.00
Increase in Cash-£386,965.00£834,930.00
Income20202019
Turnover£255,314.00£272,867.00
Cost of sales£8,547.00£4,361.00
Gross Profit£246,767.00£268,506.00
Operating Profit-£685,722.00-£609,679.00
Pre-Tax profit-£717,534.00-£638,654.00

Iq-Ai Limited Company Background

SectorHealthcare
ActivitiesIQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies.Its geographical segment includes Jersey and the United States of America. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
Latest Interim Date27 Aug 2021
Latest Fiscal Year End Date20 Apr 2021

Iq-Ai Limited Directors

AppointedNamePosition
2016-05-06Mr. Stephen Sands CookExecutive Director,Chief Executive Officer and Company Secretary
2013-04-26Mr. John Henwood MBENon-Executive Director
2013-01-23Mr. Timothy Hugh Southcombe Trotter Non-Executive Director,Chairman
2013-04-30Mr. Paul R DavidsonNon-Executive Director,Chairman
2012-05-01Mr. Anthony GeeExecutive Director,Group Finance Director and Company sec
2013-04-26Mr. Gerald VoisinNon-Executive Director
2006-11-29Mr. Paul Ian FraserNon-Executive Director,Chairman
2011-08-09Mr. Mark Tristam Norwood DugdaleExecutive Director,Chief Executive
2011-08-09Mr. Graham Norton FCAExecutive Director,Finance Director and Company Secretary
2021-12-13Mr. Trevor Edward BrownExecutive Director,Chief Executive Officer
2018-05-07Dr. Qu LiNon-Executive Director,Chairman
2022-01-04Mr. Michael SchmaindaNon-Executive Director

Iq-Ai Limited Contact Details

Company NameIQ-AI Ltd
AddressForum 4, Grenville Street, P. O. Box 264, St Helier, JE4 8TQ
Telephone
Websitehttps://www.imagingbiometrics.com

Iq-Ai Limited Advisors

SolicitorMJ Hudson
Phone+44 1534712900
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
SolicitorCharles Russell Speechlys LLP
Phone+44 2072035000
StockbrokerPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
Financial AdviserPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
AuditorWelbeck Associates
Phone+44 2074671700
BankBarclays Bank PLC
Financial PR AdviserSmithfield Consultants
Phone+44 2030472000
AuditorDeloitte LLP